Clinical Study Of Xiaoyao San In Treating Chronic Non-atrophic Gastritis Of Liver Qi Stagnation And Spleen Qi Deficiency Syndrome

Objective:The aim of this study was to observe the clinical curative effects and evaluate the clinical efficacy of Xiaoyao San in the treatment of chronic non-atrophic gastritis(CNAG)of Liver Qi Stagnation and Spleen Qi Deficiency Syndrome,in order to provide a new method and a more effective treatment plan for clinical practiceMethods:All the patients were enrolled from Gastroenterology Clinic of The Second Affiliated Hospital of Shandong University of Traditional Chinese Medicine from March 2014 to December 2014.All of their conditions are according to the characteristics of CNAG Syndrome Differentiation of Syndrome of Liver Qi Stagnation and Spleen Qi Deficiency.All the patients signed the consent form.Randomized controlled trial was used to divide 60 patients into the control group and the experimental group,30 patients in each group.Patients in the control group were given omeprazole enteric-coated capsules and aluminum magnesium carbonate tablets,the experimental group was given the Xiaoyao San and the above-mentioned medicine used in the control group.The course of treatment was 4 weeks.The clinical symptoms of each group were observed before and after treatment,so were the syndromes of liver qi stagnation and spleen qi deficiency.Results:1.There was no significant difference in the clinical efficacy between the two groups,but the clinical efficacy of the experimental group was significantly better than the control group.2.The two groups have significant differences in TCM syndrome curative effect,indicating that TCM syndrome curative effect of the experimental group was obviously better than the control group.3.The main symptoms of patients in two groups after treatment were obviously improved compared with that before treatment.The therapeutic effect of experimental group on stomach pain and belching was better than that of the control group.4.The secondary symptoms in the experimental group were markedly improved.The poor appetite in the control group of was improved.The therapeutic effect of experimental group on abdominal distension,poor appetite,depression in the experimental group were better than those in the control group.5.The total scores of primary symptoms,secondary symptoms and syndromes of the two groups were improved significantly.The total scores of secondary symptoms and syrdromes were better than those of the control group.6.The gastric mucosal lesions of two groups were improved,the efficacy of the experimental group was better than that of the control group.Conclusion:Statistics of two groups before and after treatment prove show that the treatment for experimental group can produce good results in treating Chronic Non-atrophic Gastritis of Liver Qi Stagnation and Spleen Qi Deficiency Syndrome in terms of primary symptom,secondary symptoms,primary symptom,secondary symptom and syndrome total score.The Gastroscopy,examination shows better therapeutic effects of the experimental group than those of the control group;the curative effect of TCM syndrome shows better therapeutic effects of the experimental group than those of the control group;the clinical comprehensive effective rate of the experimental group is significantly higher than that of the control group.In conclusion,XiaoYao San has curative effect in a certain degree to treat the symptoms and signs of CNAG Liver Qi Stagnation and Spleen Qi Deficiency Syndrome,and it is worthy further clinical research and promotion.